LEGOMEDIC

Microfluidics is identified by the MIT as one of the 10 top technologies which shall change the world during the next decade and opened already today amazing perspectives for health, biochemicals or fine chemicals.

In that context, MecaTech and Biowin joined their interest to launch LEGOMEDIC, a four year project aiming to the development and optimization of micro reactors for the continuous flow manufacturing and purification of organic fine chemicals and biomolecules. Coordinated by UCB-pharma, this project gathers 4 industrial partners and 4 academics partners, including CSL.